Discontinuation report KEYTRUDA
| Report ID | 72658 |
| Drug Identification Number | 02441152 |
| Brand name | KEYTRUDA |
| Common or Proper name | pembrolizumab for injection |
| Company Name | MERCK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | Pembrolizumab |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50 mg |
| ATC code | L01XC |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-12-20 |
| Actual discontinuation date | 2019-12-05 |
| Remaining supply date | 2019-12-04 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2019-12-06 | French | Compare |
| v12 | 2019-12-04 | French | Compare |
| v11 | 2019-12-04 | English | Compare |
| v10 | 2019-12-04 | English | Compare |
| v9 | 2019-09-25 | French | Compare |
| v8 | 2019-09-25 | English | Compare |
| v7 | 2019-09-25 | English | Compare |
| v6 | 2019-06-28 | French | Compare |
| v5 | 2019-06-28 | English | Compare |
| v4 | 2019-02-27 | French | Compare |
| v3 | 2019-02-27 | English | Compare |
| v2 | 2019-01-16 | French | Compare |
| v1 | 2019-01-16 | English | Compare |
Showing 1 to 13 of 13